Enovis (ENOV) Current Taxes (2010 - 2011)

Enovis' (ENOV) quarterly Current Taxes came in at $4.9 million in Q4 2011, down 20.44% year-on-year from $6.2 million in Q4 2010, and down 23.87% on a QoQ basis from $6.5 million in Q3 2011.

Enovis (ENOV) Current Taxes (2010 - 2011) Analysis & Trends

Enovis (ENOV) has 2 years of Current Taxes data on file, last reported at $4.9 million in Q4 2011.

  • On a quarterly basis, Current Taxes fell 20.44% year-over-year to $4.9 million in Q4 2011; TTM through Dec 2011 was $4.9 million, a 20.44% decrease from a year earlier, with the FY2011 full-year figure at $4.9 million, down 20.44% from the prior year.
  • Current Taxes for Q4 2011 stood at $4.9 million, down from $6.5 million in the prior quarter.
  • Over the last five years, Current Taxes for ENOV reached as high as $7.5 million in Q3 2011 and fell as low as $4.9 million in Q4 2011.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Taxes (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 598.00 Mn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 476.00 Mn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 914.00 Mn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 231.81 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -
9 Smith & Nephew 25.80 Bn 25.22 Bn - 194.00 Mn
10 Enovis 1.50 Bn 1.47 Bn 365.49 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2011 4.91 Mn
Sep 30, 2011 6.45 Mn
Jul 1, 2011 7.46 Mn
Dec 31, 2010 6.17 Mn